75N94026F00002↗
Duke University received this contract from National Institutes of Health Nichd, National Institutes of Health: $8.30M obligated so far for health r&d services; health care services; basic research. It runs to 2030-09-27.
Key facts · data as of Oct 25, 2026
- Recipient
- Duke University
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Nichd (75N940)
- Obligated to date
- $8.30M
- Potential value
- $8.30M
- Ends
- 2030-09-27
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75N94026F00002, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75N94026F00002_7529_75N94025D00003_7529
Duke University: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Nichd: what it buys
NICHD: R&D: BESPOKE GENE THERAPY CONSORTIUM (BGTC) - SUPPORT FOR NIH-SPONSORED CLINICAL TRIALS: NON-SEVERABLE
What it is
- Product or service
- Health R&D Services; Health Care Services; Basic Research (PSC AN11)
- Industry
- Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
- Contracting office
- National Institutes of Health Nichd (75N940)
- Competition
- Full and open competition
- Pricing
- Cost no fee
- How it was bought
- Single-award IDIQ · under 75N94025D00003
- Where the work is
- Durham, NC · district NC-04
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
1 action since 2026-09-24. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-24 | 0 | $8.30M | NICHD: R&D: BESPOKE GENE THERAPY CONSORTIUM (BGTC) - SUPPORT FOR NIH-SPONSORED CLINICAL TRIALS: NON-SEVERABLE |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗